239 related articles for article (PubMed ID: 16214094)
1. B-cell differentiation in the CNS of patients with multiple sclerosis.
Corcione A; Aloisi F; Serafini B; Capello E; Mancardi GL; Pistoia V; Uccelli A
Autoimmun Rev; 2005 Nov; 4(8):549-54. PubMed ID: 16214094
[TBL] [Abstract][Full Text] [Related]
2. Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis.
Corcione A; Casazza S; Ferretti E; Giunti D; Zappia E; Pistorio A; Gambini C; Mancardi GL; Uccelli A; Pistoia V
Proc Natl Acad Sci U S A; 2004 Jul; 101(30):11064-9. PubMed ID: 15263096
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of the adaptive immune response inside the central nervous system during inflammatory and autoimmune diseases.
Pedemonte E; Mancardi G; Giunti D; Corcione A; Benvenuto F; Pistoia V; Uccelli A
Pharmacol Ther; 2006 Sep; 111(3):555-66. PubMed ID: 16442633
[TBL] [Abstract][Full Text] [Related]
4. Unveiling the enigma of the CNS as a B-cell fostering environment.
Uccelli A; Aloisi F; Pistoia V
Trends Immunol; 2005 May; 26(5):254-9. PubMed ID: 15866238
[TBL] [Abstract][Full Text] [Related]
5. Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment.
Krumbholz M; Theil D; Cepok S; Hemmer B; Kivisäkk P; Ransohoff RM; Hofbauer M; Farina C; Derfuss T; Hartle C; Newcombe J; Hohlfeld R; Meinl E
Brain; 2006 Jan; 129(Pt 1):200-11. PubMed ID: 16280350
[TBL] [Abstract][Full Text] [Related]
6. B lineage cells in the inflammatory central nervous system environment: migration, maintenance, local antibody production, and therapeutic modulation.
Meinl E; Krumbholz M; Hohlfeld R
Ann Neurol; 2006 Jun; 59(6):880-92. PubMed ID: 16718690
[TBL] [Abstract][Full Text] [Related]
7. B cells and multiple sclerosis.
Franciotta D; Salvetti M; Lolli F; Serafini B; Aloisi F
Lancet Neurol; 2008 Sep; 7(9):852-8. PubMed ID: 18703007
[TBL] [Abstract][Full Text] [Related]
8. Short-lived plasma blasts are the main B cell effector subset during the course of multiple sclerosis.
Cepok S; Rosche B; Grummel V; Vogel F; Zhou D; Sayn J; Sommer N; Hartung HP; Hemmer B
Brain; 2005 Jul; 128(Pt 7):1667-76. PubMed ID: 15800022
[TBL] [Abstract][Full Text] [Related]
9. Specific central nervous system recruitment of HLA-G(+) regulatory T cells in multiple sclerosis.
Huang YH; Zozulya AL; Weidenfeller C; Metz I; Buck D; Toyka KV; Brück W; Wiendl H
Ann Neurol; 2009 Aug; 66(2):171-83. PubMed ID: 19705413
[TBL] [Abstract][Full Text] [Related]
10. Compartmentalization of inflammation in the CNS: a major mechanism driving progressive multiple sclerosis.
Meinl E; Krumbholz M; Derfuss T; Junker A; Hohlfeld R
J Neurol Sci; 2008 Nov; 274(1-2):42-4. PubMed ID: 18715571
[TBL] [Abstract][Full Text] [Related]
11. Oligoclonal bands in multiple sclerosis cerebrospinal fluid: an update on methodology and clinical usefulness.
Link H; Huang YM
J Neuroimmunol; 2006 Nov; 180(1-2):17-28. PubMed ID: 16945427
[TBL] [Abstract][Full Text] [Related]
12. B-cell subsets up-regulate α4 integrin and accumulate in the cerebrospinal fluid in clinically isolated syndrome suggestive of multiple sclerosis onset.
Lee-Chang C; Zéphir H; Top I; Dubucquoi S; Trauet J; Prin L; Vermersch P
Neurosci Lett; 2011 Jan; 487(3):273-7. PubMed ID: 20970478
[TBL] [Abstract][Full Text] [Related]
13. Clonally restricted B cells in peripheral blood of multiple sclerosis patients: kappa/lambda staining patterns.
Hauser SL; Weiner HL; Ault KA
Ann Neurol; 1982 Apr; 11(4):408-12. PubMed ID: 6179457
[TBL] [Abstract][Full Text] [Related]
14. Protective Humoral Immunity in the Central Nervous System Requires Peripheral CD19-Dependent Germinal Center Formation following Coronavirus Encephalomyelitis.
Atkinson JR; Bergmann CC
J Virol; 2017 Dec; 91(23):. PubMed ID: 28931676
[TBL] [Abstract][Full Text] [Related]
15. Multiple sclerosis: a complicated picture of autoimmunity.
McFarland HF; Martin R
Nat Immunol; 2007 Sep; 8(9):913-9. PubMed ID: 17712344
[TBL] [Abstract][Full Text] [Related]
16. Clonally expanded plasma cells in the cerebrospinal fluid of patients with central nervous system autoimmune demyelination produce "oligoclonal bands".
von Büdingen HC; Gulati M; Kuenzle S; Fischer K; Rupprecht TA; Goebels N
J Neuroimmunol; 2010 Jan; 218(1-2):134-9. PubMed ID: 19900722
[TBL] [Abstract][Full Text] [Related]
17. Antibody-secreting cells in the central nervous system in an animal model of MS: Phenotype, association with disability, and in vitro production of antibody.
Pachner AR; Brady J; Narayan K
J Neuroimmunol; 2007 Oct; 190(1-2):112-20. PubMed ID: 17919740
[TBL] [Abstract][Full Text] [Related]
18. EBV in MS: guilty by association?
Lünemann JD; Münz C
Trends Immunol; 2009 Jun; 30(6):243-8. PubMed ID: 19428300
[TBL] [Abstract][Full Text] [Related]
19. Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS.
Sellebjerg F; Börnsen L; Khademi M; Krakauer M; Olsson T; Frederiksen JL; Sørensen PS
Neurology; 2009 Dec; 73(23):2003-10. PubMed ID: 19996075
[TBL] [Abstract][Full Text] [Related]
20. Accumulation of class switched IgD-IgM- memory B cells in the cerebrospinal fluid during neuroinflammation.
Cepok S; von Geldern G; Grummel V; Hochgesand S; Celik H; Hartung H; Hemmer B
J Neuroimmunol; 2006 Nov; 180(1-2):33-9. PubMed ID: 16952404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
